ABCL AbCellera Biologics Inc.
AbCellera Biologics Inc. (ABCL) Institutional Ownership
What the institutions did with ABCL last quarter, from their 13F filings. Counting managers rather than shares is the point: a single index fund adding to a position tells you far less than four hundred separate managers all deciding to. Positions as reported for the quarter ended June 30, 2026.
Every manager below opens. Subscribers can see any firm's whole portfolio — every position, its weight, and what they bought, trimmed and exited last quarter.
Sign in or subscribeLargest holders
| Manager | Shares | % of reported |
|---|---|---|
| BAKER BROS. ADVISORS LP | 33.0M | 28.4% |
| Capital World Investors | 13.6M | 11.7% |
| TWO SIGMA INVESTMENTS, LP | 10.4M | 9.0% |
| TD Waterhouse Canada Inc. | 9.6M | 8.2% |
| BANK OF AMERICA CORP /DE/ | 6.1M | 5.3% |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 4.3M | 3.7% |
| ArrowMark Colorado Holdings LLC | 4.1M | 3.5% |
| BlackRock, Inc. | 3.8M | 3.3% |
| Driehaus Capital Management LLC | 2.9M | 2.5% |
| TUDOR INVESTMENT CORP ET AL | 2.1M | 1.8% |
| MARSHALL WACE, LLP | 1.9M | 1.6% |
| UBS Group AG | 1.9M | 1.6% |
| MORGAN STANLEY | 1.7M | 1.4% |
| PRICE T ROWE ASSOCIATES INC /MD/ | 1.6M | 1.4% |
| CITADEL ADVISORS LLC | 1.6M | 1.4% |
| NATIONAL BANK OF CANADA /FI/ | 1.2M | 1.1% |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | 1.0M | 0.9% |
| RENAISSANCE TECHNOLOGIES LLC | 990.9K | 0.9% |
| Counterpoint Mutual Funds LLC | 971.6K | 0.8% |
| STATE STREET CORP | 731.4K | 0.6% |
| HRT FINANCIAL LP | 705.5K | 0.6% |
| DNB Asset Management AS | 677.5K | 0.6% |
| Guardian Partners Inc. | 596.0K | 0.5% |
| Intellectus Partners, LLC | 551.6K | 0.5% |
| Alyeska Investment Group, L.P. | 526.6K | 0.5% |
Largest changes
| Manager | Action | Previous | Current | Change |
|---|---|---|---|---|
| GOLDMAN SACHS GROUP INC | Reduced | 3.8M | 235.1K | -3.5M |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | Reduced | 7.6M | 4.3M | -3.3M |
| BANK OF AMERICA CORP /DE/ | Increased | 3.0M | 6.1M | +3.1M |
| Jefferies Financial Group Inc. | Sold Out | 2.7M | 0 | -2.7M |
| BAKER BROS. ADVISORS LP | Increased | 30.3M | 33.0M | +2.7M |
| UBS Group AG | Reduced | 4.2M | 1.9M | -2.3M |
| Alyeska Investment Group, L.P. | Reduced | 2.6M | 526.6K | -2.1M |
| PRICE T ROWE ASSOCIATES INC /MD/ | New | 0 | 1.6M | +1.6M |
| MARSHALL WACE, LLP | Increased | 359.7K | 1.9M | +1.5M |
| NATIONAL BANK OF CANADA /FI/ | Increased | 1.4K | 1.2M | +1.2M |
| Guardian Partners Inc. | Reduced | 1.8M | 596.0K | -1.2M |
| Driehaus Capital Management LLC | Reduced | 4.0M | 2.9M | -1.2M |
| Point72 Asset Management, L.P. | Sold Out | 1.1M | 0 | -1.1M |
| ARROWSTREET CAPITAL, LIMITED PARTNERSHIP | New | 0 | 1.0M | +1.0M |
| Counterpoint Mutual Funds LLC | New | 0 | 971.6K | +971.6K |
| MILLENNIUM MANAGEMENT LLC | Reduced | 1.3M | 518.6K | -776.0K |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | Reduced | 750.4K | 20.6K | -729.8K |
| DNB Asset Management AS | New | 0 | 677.5K | +677.5K |
| JANE STREET GROUP, LLC | Reduced | 847.9K | 195.3K | -652.6K |
| MORGAN STANLEY | Reduced | 2.2M | 1.7M | -555.8K |
| VOLORIDGE INVESTMENT MANAGEMENT, LLC | Reduced | 610.4K | 71.3K | -539.1K |
| HRT FINANCIAL LP | Reduced | 1.2M | 705.5K | -529.6K |
| RENAISSANCE TECHNOLOGIES LLC | Reduced | 1.5M | 990.9K | -519.7K |
| Sculptor Capital LP | New | 0 | 454.0K | +454.0K |
| SEB Asset Management AB | Sold Out | 340.3K | 0 | -340.3K |
13F filings are due 45 days after quarter end and cover long positions in U.S.-listed equities only, so this is a lagged and partial picture: shorts, bonds and foreign listings never appear. Options positions are excluded here rather than folded into the share counts. Political ownership is coming.